ARDS
ARIDIS PHARMACEUTICAL INCstockOTC
EODNov 17, 2026
0.0001USD0.000%(0.00)900
Loading…
Loading…
5,332
Healthcare
Biotechnology
HQ
Los Gatos, CA, USA
Previous Close
$0.00
Beta
66.79
52-Week High
$0.05 2026-02-10
52-Week Low
$0.00 2026-07-15
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
128,278
Avg. Vol 30D
45,969
Avg. Vol 90D
30,833
Relative Vol
0.02
53.32M
40.31M
15,712
0.04%
38.89
55.35%
41.12%
63
Nov 17, 2026
Nov 16, 2026
ICU: QUELIMMUNE® Commercial Adoption Continues; Adult AKI Study Progresses Toward 2027 Completion ·
Zacks Small Cap Research
Nov 11, 2026
ARDS Profile
aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis' advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.
ARDS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 6M | 0.00 | 2026-05-18 | -96.43% | 150.622 |
| 1Y | 0.00 | 2025-11-18 | -95.00% | 66.786 |
| 2Y | 0.00 | 2024-11-18 | +9900.00% | — |
| 5Y | 2.32 | 2021-11-18 | -100.00% | -15.630 |
ARDS Stock Summary
ARIDIS PHARMACEUTICAL INC (OTC:ARDS) stock price today is $0.00, and today's volume is 900. ARDS is up 0.000% today. The 30 day average volume is 45,969. ARDS market cap is $5,332 with 53.32M shares outstanding.